Abstract
The feasibility of using the BVS in chronic total occlusions (CTO) lesions is unknown. This study sought to assess the safety, performance and efficacy of the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS), in percutaneous CTO revascularization, under guidance of imaging techniques
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
